| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
|
Neurology
|
2001
|
6.42
|
|
2
|
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
|
Neurology
|
2006
|
3.68
|
|
3
|
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage.
|
Neurology
|
2007
|
3.38
|
|
4
|
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.
|
N Engl J Med
|
2000
|
3.23
|
|
5
|
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.
|
Neurology
|
2004
|
2.85
|
|
6
|
White matter hyperintensity volume is increased in small vessel stroke subtypes.
|
Neurology
|
2010
|
2.49
|
|
7
|
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.
|
Neurology
|
2009
|
2.47
|
|
8
|
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength.
|
AJNR Am J Neuroradiol
|
2008
|
2.40
|
|
9
|
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review.
|
Neurology
|
2010
|
2.39
|
|
10
|
Course of cerebral amyloid angiopathy-related inflammation.
|
Neurology
|
2007
|
2.33
|
|
11
|
White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage.
|
Neurology
|
2004
|
2.07
|
|
12
|
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy.
|
Neurology
|
2006
|
2.06
|
|
13
|
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.
|
Neurology
|
2010
|
2.02
|
|
14
|
Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis.
|
Neurology
|
2002
|
1.92
|
|
15
|
A score to predict early risk of recurrence after ischemic stroke.
|
Neurology
|
2009
|
1.88
|
|
16
|
Antiplatelet use after intracerebral hemorrhage.
|
Neurology
|
2006
|
1.88
|
|
17
|
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.
|
Neurology
|
2002
|
1.82
|
|
18
|
Yeast mitochondria contain ATP-sensitive, reversible actin-binding activity.
|
Mol Biol Cell
|
1994
|
1.65
|
|
19
|
Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke.
|
Neurology
|
2009
|
1.56
|
|
20
|
Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis.
|
Neurology
|
2011
|
1.50
|
|
21
|
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy.
|
Neurology
|
2008
|
1.42
|
|
22
|
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.
|
Neurology
|
2012
|
1.30
|
|
23
|
The Causative Classification of Stroke system: an international reliability and optimization study.
|
Neurology
|
2010
|
1.19
|
|
24
|
Clinical characteristics of pathologically proved cholesterol emboli to the brain.
|
Neurology
|
2000
|
1.05
|
|
25
|
Warfarin-related intraventricular hemorrhage: imaging and outcome.
|
Neurology
|
2011
|
1.02
|
|
26
|
SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study.
|
J Vasc Interv Neurol
|
2012
|
0.88
|
|
27
|
Severity of leukoaraiosis determines clinical phenotype after brain infarction.
|
Neurology
|
2011
|
0.88
|
|
28
|
Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score.
|
AJNR Am J Neuroradiol
|
2010
|
0.86
|
|
29
|
Research and technology in neurocritical care.
|
Neurocrit Care
|
2012
|
0.86
|
|
30
|
Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy.
|
Ann N Y Acad Sci
|
2000
|
0.79
|
|
31
|
Outcome markers for clinical trials in cerebral amyloid angiopathy.
|
Amyloid
|
2001
|
0.79
|
|
32
|
Fatal phenformin-associated lactic acidosis.
|
Ann Intern Med
|
1997
|
0.77
|